139 related articles for article (PubMed ID: 29434899)
1. Preclinical study on hypoxic radiosensitizing effects of glycididazole in comparison with those of doranidazole
Yasui H; Kubota N; Nishizumi J; Sakai Y; Yamamori T; Inanami O
Oncol Lett; 2018 Feb; 15(2):1993-1998. PubMed ID: 29434899
[TBL] [Abstract][Full Text] [Related]
2. Effects of hypoxic cell radiosensitizer doranidazole (PR-350) on the radioresponse of murine and human tumor cells in vitro and in vivo.
Yahiro T; Masui S; Kubota N; Yamada K; Kobayashi A; Kishii K
J Radiat Res; 2005 Sep; 46(3):363-72. PubMed ID: 16210793
[TBL] [Abstract][Full Text] [Related]
3. The prospective application of a hypoxic radiosensitizer, doranidazole to rat intracranial glioblastoma with blood brain barrier disruption.
Yasui H; Asanuma T; Kino J; Yamamori T; Meike S; Nagane M; Kubota N; Kuwabara M; Inanami O
BMC Cancer; 2013 Mar; 13():106. PubMed ID: 23496909
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitivity of human pancreatic cancer cells in vitro and in vivo, and the effect of a new hypoxic cell sensitizer, doranidazole.
Shibamoto Y; Kubota T; Kishii K; Tsujitani M
Radiother Oncol; 2000 Aug; 56(2):265-70. PubMed ID: 10927148
[TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy and pharmacokinetics of a new hypoxic cell radiosensitizer doranidazole in SUIT-2 human pancreatic cancer xenografted in mouse pancreas.
Matsuoka H; Shibamoto Y; Kubota T; Tsujitani M; Majima T
Oncol Rep; 2000; 7(1):23-6. PubMed ID: 10601585
[TBL] [Abstract][Full Text] [Related]
6. Effect of a hypoxic cell sensitizer doranidazole on the radiation-induced apoptosis of mouse L5178Y lymphoma cells.
Aoki M; Furusawa Y; Shibamoto Y; Kobayashi A; Tsujitani M
J Radiat Res; 2002 Jun; 43(2):161-6. PubMed ID: 12238330
[TBL] [Abstract][Full Text] [Related]
7. The radiosensitizing effect of doranidazole on human colorectal cancer cells exposed to high doses of irradiation.
Zhang L; Gong A; Ji J; Wu Y; Zhu X; Lv S; Lv H; Sun X
BMC Cancer; 2007 Oct; 7():188. PubMed ID: 17919337
[TBL] [Abstract][Full Text] [Related]
8. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Murata R; Tsujitani M; Horsman MR
Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
[TBL] [Abstract][Full Text] [Related]
9. Correlation of hypoxia status with radiosensitizing effects of sodium glycididazole: A preclinical study.
Yu Y; Li X; Xu H; Liu J; Dong M; Yang J; Sun L; Sun X; Xing L
Oncol Lett; 2018 May; 15(5):6481-6488. PubMed ID: 29616117
[TBL] [Abstract][Full Text] [Related]
10. Enhanced radiosensitizing by sodium glycididazole in a recurrent esophageal carcinoma tumor model.
Wu P; Liu J; Sun X; Li X; Xing L; Yu J
Oncotarget; 2017 Sep; 8(38):63871-63880. PubMed ID: 28969036
[TBL] [Abstract][Full Text] [Related]
11. Radiation-chemical properties of the hypoxic cell radiosensitizer doranidazole (PR-350).
Kuwabara M; Iida Y; Inanami O; Sawamura S; Yokoyama K; Tsujitani M
J Radiat Res; 2002 Mar; 43(1):77-88. PubMed ID: 12056332
[TBL] [Abstract][Full Text] [Related]
12. Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy.
Nemoto K; Shibamoto Y; Ohmagari J; Baba Y; Ebe K; Ariga H; Takai Y; Ouchi A; Sasai K; Shinozaki M; Tsujitani M; Sakaguchi M; Yamada S; Sakamoto K
Anticancer Drugs; 2001 Jan; 12(1):1-6. PubMed ID: 11272282
[TBL] [Abstract][Full Text] [Related]
13. In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation.
Sasai K; Fushiki M; Yukawa Y; Suyama S; Iwai H; Shibamoto Y; Nishimoto S; Takahashi M; Abe M
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1231-4. PubMed ID: 1938521
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-responsive block copolymer radiosensitizers as anticancer drug nanocarriers for enhanced chemoradiotherapy of bulky solid tumors.
Yin W; Qiang M; Ke W; Han Y; Mukerabigwi JF; Ge Z
Biomaterials; 2018 Oct; 181():360-371. PubMed ID: 30098571
[TBL] [Abstract][Full Text] [Related]
15. Sodium glycididazole enhances the radiosensitivity of laryngeal cancer cells through downregulation of ATM signaling pathway.
Zeng YC; Xing R; Zeng J; Xue M; Chi F; Xin Y; Fan GL; Wang HM; Duan QY; Sun YN; Niu N; Wu R
Tumour Biol; 2016 May; 37(5):5869-78. PubMed ID: 26586399
[TBL] [Abstract][Full Text] [Related]
16. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of the radiosensitizing effects of sanazole and nimorazole in vitro and in vivo.
Sugie C; Shibamoto Y; Ito M; Ogino H; Suzuki H; Uto Y; Nagasawa H; Hori H
J Radiat Res; 2005 Dec; 46(4):453-9. PubMed ID: 16394636
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2'-deoxyuridine activated by hypoxic irradiation.
Shibamoto Y; Tachi Y; Tanabe K; Hatta H; Nishimoto S
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):397-402. PubMed ID: 14751508
[TBL] [Abstract][Full Text] [Related]
19. Facile Preparation and Radiotherapy Application of an Amphiphilic Block Copolymer Radiosensitizer.
Zhao K; Ke W; Yin W; Li J; Qiang M; Ge Z
ACS Macro Lett; 2017 May; 6(5):556-560. PubMed ID: 35610878
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation.
Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Abe M
Jpn J Cancer Res; 1996 Jan; 87(1):98-104. PubMed ID: 8609056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
